PATIENT HISTORY:

Clinical history is not given.

PRE-OP DIAGNOSIS: Right u ear lobe
Posr‘on DIAGNOSIS: Not givgﬁ. mass.
PROCEDURE: Not given.

ADDENDA:
Addendum

ﬂuorescence in—situ hybridigatinn studies performed on the adenocarcinoma show a ratio of Her2/Neu in the centrornere of
Ehrgmgzgm: 2;? gfél.:g,illrf11§'lcattlng Iottgflexlse: ampliﬁcation in the targeted region. The ratio of cyclin-DI gene in the centromer? of
. , Ica mg cyc an ampliﬁcation in the targeted re ion wh ‘ ‘ ' ’ '
0 . g are this is assocrated With a rn n
1$35.7 /n of analyzed cells. The rattle of EGFR gene to the centromere of chromonome 71's 9.33. indicating amplificactioﬁtsginthéate Of
argeted reglnn and corresponding to hyperpioidy rate of 87.3% of analyzed cells.

 

HerE/neu and Cyctin 01 amplification ma her in identi n ' ' ' ' '
together With Other major ﬂak factors. y p fyi g those patients likely to experience shorter survival when conSidered

FINAL DIAGNOSIS:
Summary Statement

The right upper lobe demonstrates a 1.6 cm invasive moderately differentiated adenocarcinoma. There is no
angiolymphatic invasion or visceral pleurai invasion. Surgical resection margins are free of tumor. All sampled lymph
nodes are benign. Pathologic stage: T1 N0 MX.

PART 1: LYMPH MODE, “SUBCARINAL”, BIOPSY -
F-‘IVE..(5) FRAGMENTS OF LYMPH MODE WITH ANTHRACOTIC PIGMENT.

PART 2: LYMPH NUDE, “RIGHT TRACHEOBRONGHIAL ANGLE”, BIOPSY --
SIX (6) FRAGMENTS 0F LYMF’H NODE WITH ANTHRACOTIC PIGMENT.

PART 3: LYMPH MODE, “RIGHT PARATRACHEAL”, BIOPSY~
SIX (6) FRAGMENTS 0F FRAGMENTS 0F LYMPH NODE WITH ANTHRACOTIC PIGMENT.

PART 4: LYMPH NUDE, “SUBINNOMINATE”, BIOPSY ~«
TWO (2) FRAGMENTS OF REACTIVE LYMF’H NODE WITH ANTHRACOTIC PIGIVIENT.

PART 5: PLEURA, RIGHT, BIOPSY m
FRAGMENTS 0F FIBRIN WITH REACTIVE MESOTHELIAL CELLS, MACROPHAGES AND BONE MARROWI

PART 6: LUNG. RIGHT UPPER LUBE. WEDGE RESECTIONw
A. INVASIVE MODERATELY DIFFERENTIATED ADENOCARCINOMA (1.6 CM 1N DIAMETER). NO EVIDENCE OF
VI$CERAL PLEURAL 0R ANGIOLYMPHATIC INVASION. MILD LYMPHOCYTIC HOST RESPONSE.
PATHOLOGIC STAGE: T1 N0 NIX.
B. SURGICAL RESECTION MARGINS ARE FREE OF TUMOR.
0. BACKGROUND LUNG WITH EMPHYSEMATOUS CHANGE AND RESPIRATORY BRONCHIOLITIS.

PART 7: LYMPH NODE, "ANTERIOR HILAR”, BIOPSY _.
THREE (3) FRAGMENTS OF LYMPH NODE WITH ANTHRACOTIC PIGMENT.

MICROSCOPIC:
Microscopic examination substantiates the above diagnosie. Mucicarmine is negative. PAS and PAS with diastase are positive.
Elastic stain shows an intact visceral pleura.

SYNOPTIC - PRIMARY LUNG TUMORS

 

A. Location: _1_

1. REJL 3. RLL S. LUL.
2. RML 4. LLL 6. Bronchus intermedios
l3. Procedure: 1
1. Wedge/Segmental 3. Bilobectomy
2. Loboctomy 4. Pneumonectomy

C. Size of tumor {maximum dimension): L13“ cm.
1:). Satellite nodules: ;
1. Yes 2. No
D1. If yes. Where: 13‘
1. Same lobe 2. [collateral lobes 3. Central lobe
DE. Grosely noted: 3?;
1. Yes 2. No
US. Microscopic satellites: 3‘3:
1. Yes 2. No
E. Type: g
1. Invasive squamous carcinoma 11. Fetal type adenocaroinoma
2. Besaloid Squamous carcinoma 12. Small cell carcinoma
3. invasive adenocarcinoma . 13. Carcinoid
4. Brenchioloalveolar carcinoma. nonmucinous type 14. Atypical carcinoicl
5. Elronchioloalveolar carcinoma, mucinous type 15. Sarcoma
6. Large cell carcinoma { 16. Adenosquamous carcinoma
7. Clear cell carcinoma 17. Mixed non-small cell carcinoma, NOS
8. Giant cell carcinoma 18. Carcinosarcoma '
9. Sarcometoid carcinoma 19. Large cell neuroendocrine
10. Blastoma “ 20. Other
F. Architectural grade: g
1. Well 2. Moderate 3. Poor/undifferentiated
G. Nuclear grade: 2
1. Low 2. Intermediate 3. High
H. Location in lung: 3
1.Central 2. Peripheral
i. Visceral pleural invasion through elastica: g
1. Yes 2. No
J. Parietal pleural invasion: .2
1. Yes 2. No .
K. Chest wall II'IVEISIOI‘I (into skeletal muscle or eoft tissue); g
1. Yes 2. No
L. Angiolymphetic invasion: 3.
1. Yes 2. No
M. Necrosis: 1
1. $5010 2. >50%
N. Surgical margins involved; 2
1, Yes__ 2. No
0. Inﬂammatory (desmoplastic) reaction: :l_
1 . Mild 2. Moderate 3. Severe
P. N1 lymph node involvement (N1 nodes): 3
1. Yes 2. No
0 N1 hilar lymph nodes involved, number of positive lymph nodes: Q
R. Total number of N1 lymph nodes examined: g
8. Extracapsular spread of N1 lymph node metastases: Mg

1. Yes 2. NO
“i“. Mediastinat {N2} nodes involved: 2
1. Yes 2. No 3. Not applicable

U. Modiaetinal node groupie) involved (N2 nodes): N15
1. Level 4R 4. Level TR 7.1..evei41. 10. Level 7L 13. LovelEL 16. Level 2R
2. Level 5R 5. Level 9R 8. Level EL 11. Level 9L 14. Level BL 17. Level 3R
3. Level 6R 6. Level 10R 9. Level GI. 12. Level lot. 15. Level BL 18. Level 8R

V, Number of positive mediastinai N2 nodes: Q

W. Total number of mediastinal nodes N2 examined: to

X. Extracapeular spread of mediastinal lymph node N2 metastases: Ni

......_.,....

1. Yes 2. No
Y. Underlying diseasels); lﬂﬂ
1. Emphysema 4. Smokers bronchiolitie T. Pneumoooniosts. NOS
2. Bronchiectasis 5. Asthma 8. Chronic interstitial pneumonia
3. Tumorlete 8. Parenchymal scar 9. Atypical alveolar hyperplasia

Z. TNMSiege: "1‘1 NQ Mg:

